Sadhukhan K, Naskar S
Maedica (Bucur). 2023; 17(4):856-861.
PMID: 36818257
PMC: 9923082.
DOI: 10.26574/maedica.2022.17.4.856.
Prospero Ponce C, Stevenson W, Gelman R, Agarwal D, Christoforidis J
Clin Ophthalmol. 2016; 10:485-95.
PMID: 27051270
PMC: 4803238.
DOI: 10.2147/OPTH.S97947.
Asami T, Kachi S, Mohamed U, Ito Y, Terasaki H
Nagoya J Med Sci. 2015; 77(1-2):245-52.
PMID: 25797990
PMC: 4361527.
Wu W, Liu C, Wang N, Chen K, Chen T, Hwang Y
PLoS One. 2014; 9(11):e112957.
PMID: 25397749
PMC: 4232556.
DOI: 10.1371/journal.pone.0112957.
Miller J, Kim L, Wu D, Vavvas D, Eliott D, Husain D
Ophthalmic Surg Lasers Imaging Retina. 2014; 45(4):293-7.
PMID: 25037011
PMC: 4342757.
DOI: 10.3928/23258160-20140709-05.
Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space.
Stanzel B, Liu Z, Somboonthanakij S, Wongsawad W, Brinken R, Eter N
Stem Cell Reports. 2014; 2(1):64-77.
PMID: 24511471
PMC: 3916756.
DOI: 10.1016/j.stemcr.2013.11.005.
Diabetic macular edema: New promising therapies.
Al Shamsi H, Masaud J, Ghazi N
World J Diabetes. 2014; 4(6):324-38.
PMID: 24379924
PMC: 3874493.
DOI: 10.4239/wjd.v4.i6.324.
[Pharmacological vitreolysis].
Haritoglou C, Kampik A
Ophthalmologe. 2013; 110(10):935-40.
PMID: 24046166
DOI: 10.1007/s00347-013-2829-7.
Vitreomacular traction syndrome: a comparison of treatment with intravitreal plasmin enzyme vs spontaneous vitreous separation without treatment.
Codenotti M, Maestranzi G, De Benedetto U, Querques G, Della Valle P, Iuliano L
Eye (Lond). 2012; 27(1):22-7.
PMID: 23238441
PMC: 3545391.
DOI: 10.1038/eye.2012.248.
Ocriplasmin for vitreoretinal diseases.
Tsui I, Pan C, Rahimy E, Schwartz S
J Biomed Biotechnol. 2012; 2012:354979.
PMID: 23193358
PMC: 3496214.
DOI: 10.1155/2012/354979.
Efficient vitreolysis by combining plasmin and sulfur hexafluoride injection in a preclinical study in rabbit eyes.
Wu W, Liu C, Chen C, Wang N, Chen K, Chen T
Mol Vis. 2012; 18:2361-70.
PMID: 23049236
PMC: 3462594.
Pharmacologic vitreolysis.
Nazari H, Modarres-Zadeh M, Maleki A
J Ophthalmic Vis Res. 2012; 5(1):44-52.
PMID: 22737326
PMC: 3380662.
Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review.
Schneider E, Johnson M
Clin Ophthalmol. 2011; 5:1151-65.
PMID: 21887098
PMC: 3162296.
DOI: 10.2147/OPTH.S14840.
A disposable system for rapid purification of autologous plasmin as an adjunct to vitrectomy - performance and safety profile.
Hermel M, Dailey W, Trese M, Hartzer M
Graefes Arch Clin Exp Ophthalmol. 2010; 249(1):37-46.
PMID: 20680641
DOI: 10.1007/s00417-010-1466-y.
Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo.
Hermel M, Prenner J, Alabdulrazzak M, Dailey W, Hartzer M
Graefes Arch Clin Exp Ophthalmol. 2008; 247(3):331-4.
PMID: 19034484
DOI: 10.1007/s00417-008-1000-7.
Preservation of structure and immunoreactivity at the vitreoretinal interface of the rabbit eye.
Pfeffer B, Bernstein S, Bartels S
Graefes Arch Clin Exp Ophthalmol. 2008; 247(2):193-205.
PMID: 19020891
DOI: 10.1007/s00417-008-0991-4.
Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels.
Quiram P, Leverenz V, Baker R, Dang L, Giblin F, Trese M
Retina. 2007; 27(8):1090-6.
PMID: 18040251
PMC: 2702988.
DOI: 10.1097/IAE.0b013e3180654229.
Molecular biology of pharmacologic vitreolysis.
Sebag J
Trans Am Ophthalmol Soc. 2006; 103:473-94.
PMID: 17057814
PMC: 1447585.
Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients.
Sebag J, Ansari R, Suh K
Graefes Arch Clin Exp Ophthalmol. 2006; 245(4):576-80.
PMID: 16941141
DOI: 10.1007/s00417-006-0394-3.
Efficacy of plasmin enzymes and chondroitinase ABC in creating posterior vitreous separation in the pig: a masked, placebo-controlled in vivo study.
Hermel M, Schrage N
Graefes Arch Clin Exp Ophthalmol. 2006; 245(3):399-406.
PMID: 16900357
DOI: 10.1007/s00417-006-0388-1.